Skip to main content
. 2024 Oct 7;61:00469580241287752. doi: 10.1177/00469580241287752

Table 4.

Analysis of core Pharmacovigilance process indicators at the NRA, Addis Ababa, Ethiopia, 2020.

S/N Core process indicator Result Remark
1 Total no of ADR reports received in the previous year 1416 1329 ADR, 87 product quality defects
2 Current total number of reports in the NRA’s database 4019 Total no of report during data collection period
3 Percentage of total reports acknowledged/issued back to reporters 100 Using either email or post but not sure whether it is reached or not to a reporter
4 Percentage of total reports subjected to causality assessment in the past year 2 Only conducted for serious ADEs. 2 serious ADEs/800 total reports.
5 Percentage of total annual reports satisfactorily completed and submitted to NPC in the previous year - No documented data
6 Percentage of reports of therapeutic ineffectiveness received in the last year 1 1/800 reports
7 Percentage of reports on medication error reported in the previous year 0 Not frequently detected and reported
8 No of active surveillance activities are or were initiated, ongoing, or completed in the past 5 years 03 Cohort event monitoring on ARV medication, HPV vaccine